DIC - Nursing Case Study

Pathophysiology

• Primary mechanism: Widespread endothelial injury triggers systemic activation of the coagulation cascade, leading to excessive thrombin generation and fibrin deposition in the microvasculature.

• Secondary mechanism: Consumption of clotting factors and platelets ensues, resulting in a paradoxical state where both thrombosis and hemorrhage occur concurrently, exacerbating tissue ischemia and organ dysfunction.

• Key complication: Multi-organ failure may develop as microthrombi obstruct blood flow, while hemorrhagic tendencies due to depleted coagulation components increase the risk of severe bleeding events.

Patient Profile

Demographics:

67-year-old male, retired construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes Mellitus, Chronic Obstructive Pulmonary Disease (COPD)

• Current medications: Metformin, Lisinopril, Albuterol Inhaler, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe bleeding and difficulty breathing

• Key symptoms: Hematuria, purpura, dyspnea, altered mental status, chest pain

• Vital signs: Blood pressure 85/50 mmHg, heart rate 125 bpm, respiratory rate 28 breaths/min, temperature 38.9°C (102°F), oxygen saturation 88% on room air

Section 1

As the medical team begins the initial assessment, the patient's condition rapidly deteriorates. The nurse notes that the patient is experiencing increasing respiratory distress, indicated by the use of accessory muscles for breathing and worsening cyanosis. Auscultation of the lungs reveals bilateral crackles, suggesting pulmonary edema. The patient's mental status is declining further, with increased confusion and disorientation. On examination, his skin shows widespread ecchymosis and petechiae, especially on the extremities, indicating significant bleeding tendencies. Capillary refill is delayed, and peripheral pulses are weak and thready, consistent with hypoperfusion.

Lab results return, revealing critical abnormalities that confirm the diagnosis of Disseminated Intravascular Coagulation (DIC). The complete blood count shows a substantial drop in platelet count to 40,000/mm³, and the coagulation profile is markedly deranged with a prolonged prothrombin time (PT) of 25 seconds and an activated partial thromboplastin time (aPTT) of 50 seconds. Fibrinogen levels are severely depleted at 80 mg/dL, and D-dimer is significantly elevated, supporting the ongoing systemic clotting and fibrinolysis. Renal function tests reveal an acute rise in creatinine to 2.5 mg/dL, indicating worsening kidney function, likely due to microvascular obstruction and hypoperfusion.

The patient is transferred to the intensive care unit for closer monitoring and aggressive management. Despite the initiation of supportive measures, including oxygen supplementation and fluid resuscitation, his hemodynamic status remains unstable, necessitating the initiation of vasopressor therapy. The clinical team faces the challenge of balancing the need for anticoagulation to manage the thrombotic aspect of DIC against the significant risk of hemorrhage. Plans are made for transfusion of platelets and fresh frozen plasma to address the coagulopathy, while continuous renal replacement therapy is considered for the acute kidney injury. The complexity of the case demands vigilant reassessment, multidisciplinary collaboration, and advanced critical thinking to navigate the evolving clinical picture and prevent further organ dysfunction.

Section 2

As the patient continues to be closely monitored in the intensive care unit, his condition takes a concerning turn. Despite the administration of vasopressors, his blood pressure remains critically low, with readings fluctuating around 80/50 mmHg, indicating refractory shock. The heart rate persists at a tachycardic rate of 130 beats per minute, and his respiratory rate is elevated at 30 breaths per minute, with persistent use of accessory muscles. Oxygen saturation drops to 85% on a non-rebreather mask, prompting the critical care team to initiate mechanical ventilation to support respiratory function and optimize oxygen delivery.

The new set of diagnostic results reveals further deterioration. The patient's arterial blood gas analysis indicates severe metabolic acidosis, with a pH of 7.25 and a bicarbonate level of 15 mEq/L, suggesting inadequate perfusion and worsening lactic acidosis. His lactate level is alarmingly high at 6 mmol/L, confirming the severity of tissue hypoxia and ongoing shock. The complete metabolic panel now shows worsening liver function, with elevated liver enzymes: AST at 250 U/L and ALT at 190 U/L, indicating potential hepatic injury possibly related to microvascular thrombosis and systemic hypoperfusion. Moreover, the patient's urine output has decreased significantly to less than 20 mL/hr, raising concerns for acute renal failure progression.

In light of these developments, the clinical team must re-evaluate the current management plan and consider additional interventions. The need for continuous renal replacement therapy becomes more pressing to address both the renal failure and the severe acidosis. The team also contemplates the initiation of low-dose heparin infusion to mitigate the thrombotic component of DIC, despite the ongoing risk of bleeding, especially given the critical decline in organ function. This decision requires a delicate balance and thorough risk assessment, highlighting the complexity of the case and necessitating astute clinical judgment and interdisciplinary collaboration to navigate the patient's precarious state.

Section 3

As the critical care team implements continuous renal replacement therapy (CRRT) and initiates a low-dose heparin infusion, they closely monitor the patient's response to these interventions. Within the first few hours, the patient's hemodynamic status shows some slight improvement, as indicated by a modest increase in blood pressure to 90/55 mmHg. Despite this, the heart rate remains elevated at 125 beats per minute. Mechanical ventilation has helped stabilize oxygen saturation, which now hovers around 92%, but the patient remains in a state of respiratory distress, as noted by persistent use of accessory muscles and rapid shallow breathing.

New diagnostic results present a mixed picture. While CRRT has begun to correct the severe metabolic acidosis, with the latest arterial blood gas showing a pH of 7.30 and bicarbonate level rising to 18 mEq/L, the lactate level remains critically high at 5.5 mmol/L, indicating ongoing tissue hypoxia. The patient's renal function continues to deteriorate, with serum creatinine climbing to 3.8 mg/dL and blood urea nitrogen at 45 mg/dL, reinforcing the severity of acute kidney injury. Liver enzymes are slightly improved, suggesting transient hepatic recovery, but remain elevated with AST at 220 U/L and ALT at 180 U/L, underscoring the systemic impact of DIC.

Despite the measures taken, the patient develops a new complication: diffuse bleeding from intravenous sites and mucosal surfaces, a manifestation of consumptive coagulopathy. The platelet count has plummeted to 25,000/µL, and coagulation studies reveal a further prolonged prothrombin time (PT) of 22 seconds and an activated partial thromboplastin time (aPTT) of 60 seconds. This bleeding risk poses a significant challenge to the ongoing heparin therapy, compelling the team to reassess the balance between anticoagulation and hemostatic support. The critical care team prepares for potential transfusions of platelets and fresh frozen plasma to manage this latest complication, as they continue to navigate the intricate path of treating DIC amidst multi-organ dysfunction.

Section 4

As the critical care team continues to grapple with the complexities of the patient's condition, a sudden drop in blood pressure to 75/45 mmHg signals a new and pressing challenge: the onset of septic shock. The heart rate surges further to 135 beats per minute, and the patient's skin becomes increasingly cool and clammy, indicative of peripheral vasoconstriction. The combination of hypotension and tachycardia exacerbates the existing respiratory distress, with oxygen saturation now precariously dipping to 88% despite maximal ventilatory support. These alarming changes prompt the team to swiftly escalate vasopressor therapy, adding norepinephrine to the existing support regimen to stabilize hemodynamics.

In the face of this deteriorating status, a repeat set of diagnostic tests reveals a persistent rise in inflammatory markers, with the C-reactive protein surging to 250 mg/L and procalcitonin at 30 ng/mL, underscoring a severe systemic inflammatory response. Blood cultures, drawn prior to the initiation of broad-spectrum antibiotics, return positive for gram-negative bacilli, confirming a bloodstream infection as a complicating factor in the patient's DIC. The renal function shows no signs of improvement, with creatinine creeping up to 4.2 mg/dL, and the liver enzymes remain elevated, providing further evidence of ongoing multi-organ dysfunction.

Faced with these new complications, the clinical team must engage in advanced critical thinking to adjust the treatment plan. The challenge lies in optimizing the delicate balance between aggressive infection management and maintaining hemostatic integrity. With the initiation of targeted antibiotic therapy based on culture results, the team also considers the potential need for adjunctive therapies, such as corticosteroids, to modulate the inflammatory response. Concurrently, they must vigilantly monitor for signs of worsening bleeding, ready to intervene with additional blood product transfusions as necessary. This evolving scenario demands a dynamic and nuanced approach, as the team navigates the intricate landscape of severe sepsis, DIC, and multi-organ failure.

Section 5

As the clinical team intensifies their efforts to stabilize the patient, they face a new challenge: the sudden onset of acute respiratory distress syndrome (ARDS). The patient's oxygen saturation continues to plummet, now at a critical 82%, despite administration of 100% FiO2 and the recent increase in positive end-expiratory pressure (PEEP). A chest X-ray reveals diffuse bilateral pulmonary infiltrates, consistent with non-cardiogenic pulmonary edema, further complicating the patient's respiratory status. The team must now consider advanced respiratory support options, such as initiating prone positioning or even extracorporeal membrane oxygenation (ECMO), to improve gas exchange and reduce ventilator-associated lung injury.

Concurrently, the patient's coagulopathy worsens, with a drop in platelet count to 20,000/µL and a further prolongation of the prothrombin time (PT) to 35 seconds. This indicates a heightened risk of bleeding, yet the team is cautious about administering more blood products, given the potential to exacerbate pulmonary edema. They must weigh the risks and benefits of each intervention carefully, striving to maintain a fine balance between supporting hemostasis and managing the patient's deteriorating respiratory function.

In the midst of these critical developments, the team observes a notable change in the patient's neurological status. The patient, previously responsive to verbal stimuli, now exhibits signs of altered mental state, with a Glasgow Coma Scale score dropping to 8. This decline raises concerns about cerebral perfusion and potential hypoxic brain injury. The team considers the possibility of intracranial bleeding as a complication of the DIC and prepares for an urgent CT scan of the brain. The evolving clinical picture necessitates a vigilant, multidimensional approach, requiring the team to anticipate and address rapidly emerging complications while maintaining a focus on stabilizing the patient's critical functions.